Global landscape of SARS-CoV-2 genomic surveillance and data sharing.
Global landscape of SARS-CoV-2 genomic surveillance and data sharing.
复制标题
DOI:
10.1038/s41588-022-01033-y
复制
发表时间:
2022-04
期刊:
影响因子:
30.8
通讯作者:
Yu, Hongjie
中科院分区:
文献类型:
--
作者:
Chen, Zhiyuan;Azman, Andrew S.;Chen, Xinhua;Zou, Junyi;Tian, Yuyang;Sun, Ruijia;Xu, Xiangyanyu;Wu, Yani;Lu, Wanying;Ge, Shijia;Zhao, Zeyao;Yang, Juan;Leung, Daniel T.;Domman, Daryl B.;Yu, Hongjie
Genomic surveillance has shaped our understanding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. We performed a global landscape analysis on SARS-CoV-2 genomic surveillance and genomic data using a collection of country-specific data. Here, we characterize increasing circulation of the Alpha variant in early 2021, subsequently replaced by the Delta variant around May 2021. SARS-CoV-2 genomic surveillance and sequencing availability varied markedly across countries, with 45 countries performing a high level of routine genomic surveillance and 96 countries with a high availability of SARS-CoV-2 sequencing. We also observed a marked heterogeneity of sequencing percentage, sequencing technologies, turnaround time and completeness of released metadata across regions and income groups. A total of 37% of countries with explicit reporting on variants shared less than half of their sequences of variants of concern (VOCs) in public repositories. Our findings indicate an urgent need to increase timely and full sharing of sequences, the standardization of metadata files and support for countries with limited sequencing and bioinformatics capacity. Analyses on the global diversity of SARS-CoV-2 genomic surveillance across 118 countries and the extent of public availability of genomic data provide evidence to better inform SARS-CoV-2 surveillance policy.
登录
查看更多内容
DOI:
10.1126/science.abg3055
发表时间:
2021-04-09
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Davies NG;Abbott S;Barnard RC;Jarvis CI;Kucharski AJ;Munday JD;Pearson CAB;Russell TW;Tully DC;Washburne AD;Wenseleers T;Gimma A;Waites W;Wong KLM;van Zandvoort K;Silverman JD;CMMID COVID-19 Working Group;COVID-19 Genomics UK (COG-UK) Consortium;Diaz-Ordaz K;Keogh R;Eggo RM;Funk S;Jit M;Atkins KE;Edmunds WJ
通讯作者:
Edmunds WJ
影响因子:
4.5
作者:
Crawford DC;Williams SM
通讯作者:
Williams SM
影响因子:
19
作者:
Espenhain, Laura;Funk, Tjede;Muller, Luise
通讯作者:
Muller, Luise
影响因子:
28.3
作者:
Bugembe DL;Phan MVT;Ssewanyana I;Semanda P;Nansumba H;Dhaala B;Nabadda S;O'Toole ÁN;Rambaut A;Kaleebu P;Cotten M
通讯作者:
Cotten M
DOI:
10.2807/1560-7917.es.2021.26.24.2100509
发表时间:
2021-06
期刊:
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
影响因子:
--
作者:
Campbell F;Archer B;Laurenson-Schafer H;Jinnai Y;Konings F;Batra N;Pavlin B;Vandemaele K;Van Kerkhove MD;Jombart T;Morgan O;le Polain de Waroux O
通讯作者:
le Polain de Waroux O